stockrowPenumbra, Inc.
PEN Healthcare Medical Devices
Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.
- Revenue
- +15.6%
- EPS
- −8.29%
- Free cash flow
- −37.2%
- Total debt
- −10.3%
Quarter to September 2026, against a year earlier
Follow PEN
Alert me
Penumbra, Inc. (PEN) Free cash flow
Penumbra, Inc.'s free cash flow for fiscal 2025 was $174.9M, up 18.8% from $147.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $200.3M. Over the past ten years it has ranged from −$75.0M (fiscal 2022) to $174.9M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. Penumbra, Inc. ranks 18th of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $174.9M | 18.76% |
| FY2024 | $147.3M | 81.55% |
| FY2023 | $81.1M | — |
| FY2022 | −$75.0M | — |
| FY2021 | −$11.7M | — |
| FY2020 | −$58.0M | — |
| FY2019 | $4.5M | (76.34%) |
| FY2018 | $19.2M | — |
| FY2017 | −$2.3M | — |
| FY2016 | −$26.4M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $26.4M | (18.87%) |
| Jun 2026 | $32.5M | (55.60%) |
| Mar 2026 | $73.3M | 7.71% |
| Dec 2025 | $68.1M | 61.97% |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| GMED Globus Medical, Inc. compare | $766.6M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $468.1M |
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| PODD Insulet Corporation compare | $260.0M |
| BRKR Bruker Corporation compare | $244.7M |
| PEN Penumbra, Inc. | $200.3M |
| TXG 10x Genomics compare | $121.4M |
| GKOS Glaukos Corporation compare | $36.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on PEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement